New London County, Connecticut, United States
Scientist and AI strategist — I turn AI from a buzzword into tools that make drug development faster, smarter, and more patient-centric. I sit where three worlds rarely meet — clinical science, applied AI/ML, and drug-development strategy — and my job is to connect them so breakthrough medicines reach patients sooner. Here's the shape of that work: 🔬 Deep scientific roots — Pharmacist, PhD, two master's, two postdocs. 10+ years building pharmacokinetic/pharmacodynamic/pharmacogenomic and machine-learning models to explain why patients respond differently to the same drug. 🤖 AI in practice, not slideware — Built GenAI platforms that speed R&D document generation and trial startup, and ML models predicting cancer survival and drug-response differences in safety and efficacy. 💊 Drug development, end-to-end — Phase I–IV trials across Internal Medicine, Oncology, Immunology, and Infectious Disease; regulatory interactions with FDA, EMA, and PMDA. 📈 Science with reach — 100+ peer-reviewed papers & conference proceedings (NEJM, The Lancet, Circulation, CPT), ~3,500+ citations, 40+ talks at major venues. 🤝 Service to the field — ASCPT Board of Directors; editorial roles at CPT and Clinical and Translational Science; mentor to postdocs, PharmD, and graduate students. 🏆 Recognized — Pfizer's William E. Upjohn Prizes, ACCP Tanabe Young Investigator Award, UF 40 Under 40. Always glad to connect with others working at the edge of AI and life sciences.
Advisor: Dr. George Michailidis, Ph.D.
Advisor: Dr. Julie A. Johnson, Pharm.D.